The latter route has a large advantage of adding circulation time to the drug, allowing long-lasting effects of the drugs, potentially reducing the administration frequency and possibly also lowering gastrointestinal complications, as currently only subcutaneous and very few oral routes have been explored
- The global glutathione market is expected to cross $315 million by 2027
Free from allergens and well tolerated
(2017) conducted a randomized, double-blind, placebo-controlled crossover trial in 40 healthy adults, showing that 15 mg/day HTY for 3 weeks significantly increased plasma thiols, total antioxidant status, and SOD1 expression while reducing nitrite, nitrate, and MDA, and modestly lowering body fat mass, supporting HTYs anti-atherosclerotic and cardioprotective potential via improved redox balance and gene expression modulation [77]
This helps to reduce spikes in blood sugar levels, which is important for managing diabetes
Future Trends in GLP and GIP Research The future of GLP-1 and GIP research looks very bright
